NCT02247193View on ClinicalTrials.gov

Botulinum Toxin to Improve Cosmesis of Primary Cleft Lip Repair

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

January 13, 2020

Study Completion Date

January 13, 2020

Conditions
Cleft LipScarringCleft Palate
Interventions
DRUG

Botulinum Toxin Type A

Injection of botulinum toxin at the time of surgery at cleft lip repair site. Botulinum toxin will be injected intraoperatively at 4 standardized sites in the cleft lip during surgical repair.

DRUG

Normal Saline Injection

Injection of normal saline into cleft lip at time of surgical repair. Saline will be injected intraoperatively at 4 standardized sites in the cleft lip during surgical repair.

Trial Locations (1)

77030

Memorial Hermann Hospital, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT02247193 - Botulinum Toxin to Improve Cosmesis of Primary Cleft Lip Repair | Biotech Hunter | Biotech Hunter